Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 3
1999 4
2000 1
2001 2
2003 6
2004 1
2005 2
2006 5
2007 5
2008 5
2009 3
2010 4
2011 6
2012 12
2013 8
2014 15
2015 22
2016 27
2017 27
2018 13
2019 20
2020 25
2021 22
2022 24
2023 25
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Results by year

Filters applied: . Clear all
Page 1
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM; SENSCIS Trial Investigators. Distler O, et al. N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112379 Free article. Clinical Trial.
Systemic sclerosis: Advances towards stratified medicine.
Quinlivan A, Ross L, Proudman S. Quinlivan A, et al. Among authors: proudman s. Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101469. doi: 10.1016/j.berh.2019.101469. Epub 2020 Jan 21. Best Pract Res Clin Rheumatol. 2020. PMID: 31973938 Review.
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
Spiera R, Kuwana M, Khanna D, Hummers L, Frech TM, Stevens W, Matucci-Cerinic M, Kafaja S, Distler O, Jun JB, Levy Y, Leszcyzński P, Gordon J, Steen V, Lee EB, Jankowski T, Litinsky I, Chung L, Hsu V, Mayes M, Sandorfi N, Simms RW, Finzel S, de Vries-Bouwstra J, Constantine S, Dgetluck N, Dinh Q, Bloom BJ, Furst DE, White B, Denton CP; RESOLVE-1 Study Group. Spiera R, et al. Arthritis Rheumatol. 2023 Sep;75(9):1608-1618. doi: 10.1002/art.42510. Epub 2023 Jun 15. Arthritis Rheumatol. 2023. PMID: 37098795 Free article. Clinical Trial.
Mortality estimates and excess mortality in rheumatoid arthritis.
Black RJ, Lester S, Tieu J, Sinnathurai P, Barrett C, Buchbinder R, Lassere M, March L, Proudman SM, Hill CL. Black RJ, et al. Among authors: proudman sm. Rheumatology (Oxford). 2023 Nov 2;62(11):3576-3583. doi: 10.1093/rheumatology/kead106. Rheumatology (Oxford). 2023. PMID: 36919770 Free PMC article.
Musculoskeletal Manifestations of Systemic Sclerosis.
Morrisroe KB, Nikpour M, Proudman SM. Morrisroe KB, et al. Among authors: proudman sm. Rheum Dis Clin North Am. 2015 Aug;41(3):507-18. doi: 10.1016/j.rdc.2015.04.011. Epub 2015 May 26. Rheum Dis Clin North Am. 2015. PMID: 26210132 Review.
The Effect of Body Fat Distribution on Systemic Sclerosis.
Villanueva-Martin G, Acosta-Herrera M, Kerick M, López-Isac E, Simeón CP, Callejas JL, Assassi S, Beretta L, SSc Group I, Asig ASIG, Allanore Y, Proudman SM, Nikpour M, Fonseca C, Denton CP, Radstake TRDJ, Mayes MD, Jiang X, Martin J, Bossini-Castillo L. Villanueva-Martin G, et al. Among authors: proudman sm. J Clin Med. 2022 Oct 12;11(20):6014. doi: 10.3390/jcm11206014. J Clin Med. 2022. PMID: 36294335 Free PMC article.
Epidemiology of systemic sclerosis.
Nikpour M, Stevens WM, Herrick AL, Proudman SM. Nikpour M, et al. Among authors: proudman sm. Best Pract Res Clin Rheumatol. 2010 Dec;24(6):857-69. doi: 10.1016/j.berh.2010.10.007. Best Pract Res Clin Rheumatol. 2010. PMID: 21665131 Review.
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways.
López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, Beretta L, Simeón CP, Carreira P, Ortego-Centeno N, Castellvi I, Bossini-Castillo L, Carmona FD, Orozco G, Hunzelmann N, Distler JHW, Franke A, Lunardi C, Moroncini G, Gabrielli A, de Vries-Bouwstra J, Wijmenga C, Koeleman BPC, Nordin A, Padyukov L, Hoffmann-Vold AM, Lie B; European Scleroderma Group†; Proudman S, Stevens W, Nikpour M; Australian Scleroderma Interest Group (ASIG); Vyse T, Herrick AL, Worthington J, Denton CP, Allanore Y, Brown MA, Radstake TRDJ, Fonseca C, Chang HY, Mayes MD, Martin J. López-Isac E, et al. Among authors: proudman s. Nat Commun. 2019 Oct 31;10(1):4955. doi: 10.1038/s41467-019-12760-y. Nat Commun. 2019. PMID: 31672989 Free PMC article.
275 results